Current limitations include: limited long-term safety data compared with established medicines trial populations that may not represent broader real-world groups evolving phase 3 research ongoing monitoring of adverse events the need for longer follow-up across different study populations This does not make the available data unimportant
This can be seen in the specifics of the dosing regimen for RYBELSUS semaglutide tablets, which must be taken after waking, on an empty stomach, and with no more than four ounces (~120ml) of plain water
And neither does Williams
These results underscore the challenge of treating MASH
Administering these peptides on an empty stomach is crucial because insulin, which is released in response to food (especially carbohydrates), has been shown to inhibit the secretion of Growth Hormone
Hi, Brianne, thanks for hosting me today